Form 8.5 (EPT/RI)-Advanced Medical Solutions Grp

Summary by AI BETAClose X

Goldman Sachs, acting as exempt principal trader for H.B. Fuller Medical Adhesive Technologies (a wholly-owned subsidiary of H.B. Fuller), executed purchases of 192,242 5p ordinary shares and sales of 133,198 on 02 Nov 2026, netting a buy of 59,044 shares at prices between 2.8250–2.8308 GBP; associated CFD activity produced a net increase in short exposure of 42,684 reference shares (61,950 increases/openings vs 19,266 reductions) across prices 2.8228–2.8308 GBP, signaling both physical accumulation and synthetic hedging by a prospective offeror that could materially affect AMS share valuation.

Disclaimer*

UK 100